Jul 2, 2026
Podcast · Inglés
Ori Spotlight
Ori Biotech
Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect
Episodes
Ordered by publication date.
Jan 27, 2026
Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 13, 2026
Joe DePinto: Why advanced therapies need a new delivery model
Dec 16, 2025
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
Dec 3, 2025
John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later
Sep 2, 2025
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Aug 12, 2025
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
Jul 15, 2025
Henrik Andersen: How smart planning helps CGT scale further, faster
Jul 1, 2025
Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success
Jun 17, 2025
Julie Allickson: How early automation strategies reduce costs and improve patient access
Jun 3, 2025
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)
May 23, 2025
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 1)
Nov 25, 2024
Amritha Jaishankar: Advancing data integration and decentralized manufacturing for CGT access
Nov 5, 2024
Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access
Oct 8, 2024
Michael Krajewski: How does the Theory of Constraints apply to CGT manufacturing?
More related podcasts
Other podcasts in Science & Medicine.